Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson & Johnson Kick-Starts Suzhou Production

This article was originally published in PharmAsia News

Executive Summary

Johnson & Johnson Medical has commenced operation at its Suzhou Industrial Park, starting off with orthopedic implants, which have been experiencing the fastest growth in the firm's portfolio. The first DePuy factory will make products related to artificial joint replacement and trauma care to fulfill 10-20 percent of the company's global output. With other localized products coming online, the Suzhou base is set to become J&J Medical's largest production facility in the next five years. There are plans to introduce minimally invasive surgical devices by the end of this year and cardiology products in 2009. China is experiencing huge domestic demand and growth for orthopedic implants; the market is expected to increase from 500 million yuan in 2007 to 2.1 billion yuan in 2015. (Click here for more - Chinese Language)

You may also be interested in...



China Poised To Conditionally Approve First COVID Vaccine

The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.

Novartis Faces Another Challenge To Entresto In India

More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.

Cosmetic And Personal Care Trademark Review 24 November, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel